Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
METiS TechBio has entered a global licensing agreement with Boulevard Bio, granting exclusive rights to develop, manufacture, and commercialize MTS-128, an AI designed trispecific T cell engager. The deal includes $20 million upfront and up to $1.6 billion in potential milestone payments.
Marley Health has launched to bring clinical-grade AI and biomarker technology from human healthcare into veterinary practice through a smart collar and digital platform for proactive pet monitoring.
CollPlant Biotechnologies has entered into an agreement for a $2.6 million private placement of shares and warrants, with closing expected around July 1, 2026.
HiLabs has announced a multi-year research collaboration with Dr. Thomas Tsai of Harvard University to analyze ghost networks and access to care for 35 million Medicare Advantage enrollees.
InterVenn Biosciences and Aranscia have expanded their commercialization partnership to broaden access to the GlycoKnow Ovarian cancer diagnostic test, a blood-based liquid biopsy that helps distinguish malignant from benign pelvic masses.
MGI Tech’s Genoria AI and the Shanghai Artificial Intelligence Laboratory have launched ProtoPilot and BioLab Bench, two interconnected systems that bridge AI reasoning with physical lab execution in life sciences research.
SK bioscience has been selected to lead the Gates Foundation-funded ROTOR project, developing an AI platform to support evidence-based decision-making in vaccine research and enhance vaccine access for low- and middle-income countries.
Neurophet has signed an agreement to supply its brain imaging analysis software, Neurophet AQUA, to Raffles Medical in Singapore. The software enables fast quantitative analysis of MRI scans for assessing brain atrophy and white matter degeneration in neurodegenerative diseases.
Experity has acquired Exdion Healthcare to enhance its automation capabilities in revenue cycle management for urgent care operators across the United States. The acquisition enables Experity to integrate AI tools that streamline coding, billing, and compliance processes.
Alleva has introduced Alleva Intelligence, a suite of AI and analytics tools that form a connected ecosystem designed to assist behavioral health organizations with documentation, compliance, knowledge sharing, and operational insight.
ALR Technologies SG Ltd has signed a letter of intent to acquire CGM Medical Technology’s Singapore and Shenzhen operations for $45 million and 200 million shares, aiming to integrate continuous glucose monitor production.
Inductive Bio has joined Anthropic's life sciences ecosystem and launched a connector that integrates its ADMET prediction models into Claude, allowing scientists to analyze drug properties directly within the AI assistant.
Basecamp Research has made its EDEN antibiotic and vaccine design models available through Anthropic's Claude Science, allowing researchers to generate and prioritize therapeutic candidates using a conversational interface.
SciBase has submitted a 510(k) premarket notification to the U.S. FDA to expand the use of its AI device Nevisense to include non-melanoma skin cancers, aiming to broaden its clinical application beyond melanoma.
PreOncology has introduced a new oncologist-led medical specialty focused on preventing and detecting cancer before stage I, combining genomics, AI risk modeling, and personalized surveillance through its Stage Alpha Operating System.
LatusPet, a University of Oxford biotech startup, has published a peer-reviewed study demonstrating that its SINO platform can detect multiple diseases in dogs from a single blood sample with over 90% accuracy.
One Brooklyn Health has chosen hellocare.ai to implement AI assisted virtual nursing and patient monitoring across its hospitals, introducing real time AI models for fall prevention and patient safety.
Ozelle will debut its new automated hematology analyzer, O-Cyte 1, at ADLM 2026 in California. The system uses AI to deliver morphology intelligence and scalable throughput for clinical laboratories.
Xellar Biosystems has secured $50 million in Series A and A+ funding to advance its 3D Bio Intelligence platform that integrates organ-on-chip systems, automation, imaging, multi-omics, and AI modeling for drug discovery.
4DMedical has received approval from the Australian Therapeutic Goods Administration for its CT:VQ imaging technology, enabling contrast-free ventilation and perfusion imaging using standard chest CT scans.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
